Skip to main content
Equibles

Joel Isaacson & Co., LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1599330 NEW YORK, NY
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$802,032
+$139,769 QoQ
Shares Held
10,247
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#333
of 667 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Joel Isaacson & Co., LLC holds $3,465,389 across 6 Biotechnology names. HALO ranks #2 (23.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 3,067 $1,912,397
2 HALO
Halozyme Therapeutics, Inc.
This page 		10,247 $802,032
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 575 $285,619
4 EDIT
Editas Medicine, Inc.
 68,144 $220,786
5 IBRX
ImmunityBio, Inc.
 25,000 $218,875
6 CGEN
Compugen Ltd
 12,000 $25,680

All Filings in HALO

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $802,032 10,247
2026-03-31 $662,263 10,247
2025-12-31 $689,623 10,247
2025-09-30 $751,514 10,247
2025-06-30 $533,048 10,247
2025-03-31 $653,861 10,247
2024-12-31 $489,909 10,247
2024-09-30 $598,844 10,462
2024-06-30 $547,790 10,462
2024-03-31 $425,594 10,462
2023-12-31 $386,675 10,462
2023-09-30 $399,648 10,462
2023-06-30 $377,364 10,462
2023-03-31 $399,543 10,462
2022-12-31 $595,287 10,462
2022-09-30 $413,667 10,462
2022-06-30 $460,328 10,462
2022-03-31 $428,710 10,750
2021-12-31 $432,257 10,750
2021-09-30 $437,310 10,750
2021-06-30 $488,157 10,750
2021-03-31 $448,167 10,750
2020-12-31 $384,390 9,000